02/12/202403/12/2024 Helix Biopharma Corp. Enters into Asset Purchase Agreement to Acquire Oral Gemcitabine Chemotherapy Compound admin 0 Comments
29/11/202403/12/2024 Helix Biopharma Corp. Enters into Asset Purchase Agreement to Acquire Oral Immune Checkpoint Inhibitor and Expand Immune-Oncology Portfolio admin 1 Comment
13/11/202414/11/2024 Helix Biopharma Corp. Enters into Non-Binding Letter of Intent to Acquire Laevoroc Group’s Oncology Assets admin 0 Comments
08/11/202409/11/2024 Helix Biopharma Corp. Announces CFO and Corporate Secretary Resignation admin 0 Comments
